CATALYST PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Attached files

file	filename
10-K - FORM 10-K - CATALYST PHARMACEUTICALS, INC.	d10k.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - CATALYST PHARMACEUTICALS, INC.	dex321.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - CATALYST PHARMACEUTICALS, INC.	dex311.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - CATALYST PHARMACEUTICALS, INC.	dex312.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - CATALYST PHARMACEUTICALS, INC.	dex322.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our report dated March 31, 2010, with respect to the financial statements included in the Annual Report of Catalyst Pharmaceutical Partners, Inc. on Form 10-K for the year ended December 31,2009. We hereby consent to the incorporation by reference of said report in the Registration Statements of Catalyst Pharmaceutical Partners, Inc. on Forms S-8 (File No. 333-151367, effective June 2, 2008 and File No. 333-151369, effective June 2, 2008) and Form S-3 (File No. 333-151368, effective June 2, 2008).

/s/ GRANT THORNTON LLP

Miami, Florida

March 31, 2010

Attached files

Stock widget

Investing forum

CATALYST PHARMACEUTICALS, INC. Reports